| human | Q5 |
| P227 | GND ID | 1159594791 |
| P496 | ORCID iD | 0000-0003-1277-310X |
| P214 | VIAF ID | 21152682550723312841 |
| P735 | given name | Thomas | Q16428906 |
| Thomas | Q16428906 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q35669888 | A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma |
| Q39485541 | A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat |
| Q36631618 | Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. |
| Q55463035 | Adult medulloblastoma comprises three major molecular variants. |
| Q38202605 | Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity |
| Q48262403 | Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology |
| Q55462417 | Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. |
| Q38650700 | Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial. |
| Q56967302 | Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma |
| Q97544977 | CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas |
| Q34966234 | Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation |
| Q36366654 | Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma |
| Q58085845 | Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p |
| Q64025789 | Comparison of Peripheral Zone and Central Gland Volume in Patients Undergoing Intensity-Modulated Radiotherapy |
| Q59092325 | Corrigendum: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma |
| Q92913420 | Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma |
| Q91236245 | Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma |
| Q38743450 | DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis |
| Q34132926 | Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma |
| Q29616862 | Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma |
| Q64025780 | Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals |
| Q37706929 | Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing |
| Q34215755 | FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma |
| Q48229405 | Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. |
| Q48329991 | Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma |
| Q30849501 | Hyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner. |
| Q87490030 | Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma |
| Q64915696 | LGG-11. REGULATION OF ONCOGENE-INDUCED SENESCENCE IN PILOCYTIC ASTROCYTOMA. |
| Q104795014 | Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma |
| Q41230411 | Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation. |
| Q52600222 | Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. |
| Q36920479 | Medulloblastoma comprises four distinct molecular variants |
| Q53201641 | MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. |
| Q46526605 | Molecular staging of intracranial ependymoma in children and adults |
| Q43662312 | Nestin expression identifies ependymoma patients with poor outcome |
| Q37745480 | Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival. |
| Q94406653 | PDTM-47. CHARACTERIZATION OF THE SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE IN PILOCYTIC ASTROCYTOMA AND ITS ROLE IN ONCOGENE-INDUCED SENESCENCE |
| Q39888054 | Pathogenetic pathways leading to glioblastoma multiforme: association between gene expressions and resistance to erlotinib. |
| Q52148322 | Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors. |
| Q35960250 | Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct |
| Q42335813 | Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. |
| Q64025788 | Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma |
| Q39158460 | Prognostic relevance of miRNA-155 methylation in anaplastic glioma |
| Q40691084 | Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study |
| Q49752739 | Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation |
| Q37004219 | Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis |
| Q35999062 | Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transpla |
| Q89602885 | Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial |
| Q30156001 | Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma |
| Q50744249 | Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma |
| Q99244111 | Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria |
| Q35800851 | Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial. |
| Q91822770 | Susceptibility-weighted imaging in malignant melanoma brain metastasis |
| Q36849156 | TERT Promoter Mutations and Risk of Recurrence in Meningioma |
| Q35246513 | Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma |
| Q90365196 | The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma |
| Q28291406 | The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation |
| Q37130238 | Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis |
| Q41176897 | Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. |
| Q34394233 | mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy |
Search more.